Animal models of prenatal immune challenge and their contribution to the study of schizophrenia: a systematic review

Prenatal immune challenge (PIC) in pregnant rodents produces offspring with abnormalities in behavior, histology, and gene expression that are reminiscent of schizophrenia and autism. Based on this, the goal of this article was to review the main contributions of PIC models, especially the one using the viral-mimetic particle polyriboinosinic-polyribocytidylic acid (poly-I:C), to the understanding of the etiology, biological basis and treatment of schizophrenia. This systematic review consisted of a search of available web databases (PubMed, SciELO, LILACS, PsycINFO, and ISI Web of Knowledge) for original studies published in the last 10 years (May 2001 to October 2011) concerning animal models of PIC, focusing on those using poly-I:C. The results showed that the PIC model with poly-I:C is able to mimic the prodrome and both the positive and negative/cognitive dimensions of schizophrenia, depending on the specific gestation time window of the immune challenge. The model resembles the neurobiology and etiology of schizophrenia and has good predictive value. In conclusion, this model is a robust tool for the identification of novel molecular targets during prenatal life, adolescence and adulthood that might contribute to the development of preventive and/or treatment strategies (targeting specific symptoms, i.e., positive or negative/cognitive) for this devastating mental disorder, also presenting biosafety as compared to viral infection models. One limitation of this model is the incapacity to model the full spectrum of immune responses normally induced by viral exposure.

[1]  J. Feldon,et al.  To poly(I:C) or not to poly(I:C): Advancing preclinical schizophrenia research through the use of prenatal immune activation models , 2012, Neuropharmacology.

[2]  I. Weiner,et al.  Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. , 2011, Schizophrenia bulletin.

[3]  H. Fukumitsu,et al.  Prenatal immune challenge compromises development of upper‐layer but not deeper‐layer neurons of the mouse cerebral cortex , 2011, Journal of neuroscience research.

[4]  P. Horn,et al.  Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation. , 2011, Journal of psychiatric research.

[5]  G. Gudelsky,et al.  Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801 , 2011, Neuroscience Letters.

[6]  P. Mcguire,et al.  Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[7]  Urs Meyer,et al.  Schizophrenia and Autism: Both Shared and Disorder-Specific Pathogenesis Via Perinatal Inflammation? , 2011, Pediatric Research.

[8]  Christos Pantelis,et al.  Age of onset of schizophrenia: perspectives from structural neuroimaging studies. , 2011, Schizophrenia bulletin.

[9]  P. Patterson,et al.  Activation of the maternal immune system induces endocrine changes in the placenta via IL-6 , 2011, Brain, Behavior, and Immunity.

[10]  Terrell Holloway,et al.  Maternal Influenza Viral Infection Causes Schizophrenia-Like Alterations of 5-HT2A and mGlu2 Receptors in the Adult Offspring , 2011, The Journal of Neuroscience.

[11]  P. Mcguire,et al.  Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis , 2011, Schizophrenia Research.

[12]  A. Dwork,et al.  Searching for Neuropathology: Gliosis in Schizophrenia , 2011, Biological Psychiatry.

[13]  S. Obayashi,et al.  Maternal immune activation by polyriboinosinic-polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring , 2010, Brain Research.

[14]  H. Moore The role of rodent models in the discovery of new treatments for schizophrenia: updating our strategy. , 2010, Schizophrenia bulletin.

[15]  K. Yaddanapudi,et al.  Induction of Toll-Like Receptor 3-Mediated Immunity during Gestation Inhibits Cortical Neurogenesis and Causes Behavioral Disturbances , 2010, mBio.

[16]  S. Hyman,et al.  Animal models of neuropsychiatric disorders , 2010, Nature Neuroscience.

[17]  Richard S. Ehrlichman,et al.  Mouse behavioral endophenotypes for schizophrenia , 2010, Brain Research Bulletin.

[18]  D. Bilkey,et al.  Abnormal Long-Range Neural Synchrony in a Maternal Immune Activation Animal Model of Schizophrenia , 2010, The Journal of Neuroscience.

[19]  J. Feldon,et al.  Late Prenatal Immune Activation in Mice Leads to Behavioral and Neurochemical Abnormalities Relevant to the Negative Symptoms of Schizophrenia , 2010, Neuropsychopharmacology.

[20]  P. Patterson,et al.  Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring , 2010, Brain, Behavior, and Immunity.

[21]  Qi Li,et al.  Voxel-based analysis of postnatal white matter microstructure in mice exposed to immune challenge in early or late pregnancy , 2010, NeuroImage.

[22]  J. Feldon,et al.  Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. , 2010, Schizophrenia bulletin.

[23]  N. Ron-Harel,et al.  Dysregulation of kisspeptin and neurogenesis at adolescence link inborn immune deficits to the late onset of abnormal sensorimotor gating in congenital psychological disorders , 2010, Molecular Psychiatry.

[24]  Alan S. Brown,et al.  Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. , 2010, The American journal of psychiatry.

[25]  J. Feldon,et al.  A LONGITUDINAL EXAMINATION OF THE NEURODEVELOPMENTAL IMPACT OF PRENATAL IMMUNE ACTIVATION IN MICE REVEALS PRIMARY DEFECTS IN DOPAMINERGIC DEVELOPMENT RELEVANT TO SCHIZOPHRENIA , 2010, Schizophrenia Research.

[26]  J. Feldon,et al.  Neural basis of psychosis-related behaviour in the infection model of schizophrenia , 2009, Behavioural Brain Research.

[27]  I. Weiner,et al.  Clozapine Administration in Adolescence Prevents Postpubertal Emergence of Brain Structural Pathology in an Animal Model of Schizophrenia , 2009, Biological Psychiatry.

[28]  Urs Meyer,et al.  Prenatal Immune Challenge Is an Environmental Risk Factor for Brain and Behavior Change Relevant to Schizophrenia: Evidence from MRI in a Mouse Model , 2009, PloS one.

[29]  T. Nabeshima,et al.  Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood , 2009, Neuroscience Research.

[30]  J. Feldon,et al.  Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. , 2009, The international journal of neuropsychopharmacology.

[31]  S. Fatemi,et al.  The neurodevelopmental hypothesis of schizophrenia, revisited. , 2009, Schizophrenia bulletin.

[32]  Limin Shi,et al.  Activation of the maternal immune system alters cerebellar development in the offspring , 2009, Brain, Behavior, and Immunity.

[33]  T. Kishimoto,et al.  Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring , 2008, Journal of neuroscience research.

[34]  D. Bilkey,et al.  Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring , 2008, Behavioural Brain Research.

[35]  J. Feldon,et al.  Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy , 2008, Neuroscience.

[36]  Urs Meyer,et al.  Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice , 2008, Brain, Behavior, and Immunity.

[37]  J. Feldon,et al.  Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling , 2008, Molecular Psychiatry.

[38]  K. Mirnics,et al.  Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6 , 2007, The Journal of Neuroscience.

[39]  P. Boksa,et al.  Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy , 2007, Behavioural Brain Research.

[40]  M. Geyer,et al.  Towards Understanding The Schizophrenia Code : An Expanded Convergent Functional Genomics Approach , 2007 .

[41]  D. Dietz,et al.  Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus , 2007, Behavioural Brain Research.

[42]  Urs Meyer,et al.  Immunological stress at the maternal–foetal interface: A link between neurodevelopment and adult psychopathology , 2006, Brain, Behavior, and Immunity.

[43]  João Vinícius Salgado,et al.  Modelos experimentais de esquizofrenia: uma revisão , 2006 .

[44]  G. Sandner,et al.  [Experimental models of schizophrenia--a review]. , 2006, Revista brasileira de psiquiatria.

[45]  Urs Meyer,et al.  The Time of Prenatal Immune Challenge Determines the Specificity of Inflammation-Mediated Brain and Behavioral Pathology , 2006, The Journal of Neuroscience.

[46]  J. Feldon,et al.  Prenatal and postnatal maternal contributions in the infection model of schizophrenia , 2006, Experimental Brain Research.

[47]  K. Hashimoto,et al.  Immune Activation During Pregnancy in Mice Leads to Dopaminergic Hyperfunction and Cognitive Impairment in the Offspring: A Neurodevelopmental Animal Model of Schizophrenia , 2006, Biological Psychiatry.

[48]  M. Cannon,et al.  The role of obstetric events in schizophrenia. , 2005, Schizophrenia bulletin.

[49]  Urs Meyer,et al.  Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia , 2005, Neuroscience & Biobehavioral Reviews.

[50]  I. Weiner,et al.  Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. , 2005, Journal of psychiatric research.

[51]  J. McGrath,et al.  A Systematic Review of the Prevalence of Schizophrenia , 2005, PLoS medicine.

[52]  J. Gilmore,et al.  Maternal poly I:C exposure during pregnancy regulates TNFα, BDNF, and NGF expression in neonatal brain and the maternal–fetal unit of the rat , 2005, Journal of Neuroimmunology.

[53]  E. Fikrig,et al.  Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis , 2004, Nature Medicine.

[54]  Kyoko Koshibu,et al.  Sex-specific, postpuberty changes in mouse brain structures revealed by three-dimensional magnetic resonance microscopy , 2004, NeuroImage.

[55]  S. Akira,et al.  Interferon response induced by Toll-like receptor signaling , 2004, Journal of endotoxin research.

[56]  Sukanta Saha,et al.  A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology , 2004, BMC medicine.

[57]  Renato Luiz Marchetti Bases biológicas dos transtornos psiquiátricos , 2004 .

[58]  I. Weiner,et al.  Immune Activation During Pregnancy in Rats Leads to a PostPubertal Emergence of Disrupted Latent Inhibition, Dopaminergic Hyperfunction, and Altered Limbic Morphology in the Offspring: A Novel Neurodevelopmental Model of Schizophrenia , 2003, Neuropsychopharmacology.

[59]  I. Weiner,et al.  Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation , 2003, Psychopharmacology.

[60]  Peter B. Jones,et al.  The Clinical Global Impression–Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia , 2003, Acta psychiatrica Scandinavica. Supplementum.

[61]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[62]  Limin Shi,et al.  Maternal Influenza Infection Causes Marked Behavioral and Pharmacological Changes in the Offspring , 2003, The Journal of Neuroscience.

[63]  J. Borrell,et al.  Prenatal Immune Challenge Disrupts Sensorimotor Gating in Adult Rats: Implications for the Etiopathogenesis of Schizophrenia , 2002, Neuropsychopharmacology.

[64]  E. Susser,et al.  In utero infection and adult schizophrenia. , 2002, Mental retardation and developmental disabilities research reviews.

[65]  B. Pearce,et al.  Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms , 2001, Molecular Psychiatry.

[66]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[67]  Ângela Miranda Scippa Bases Biológicas dos Transtornos Psiquiátricos , 2000 .

[68]  N. Andreasen A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly. , 1999, Archives of general psychiatry.

[69]  Paul J. Harrison Brains at risk of schizophrenia , 1999, The Lancet.

[70]  J. Schulenburg,et al.  Die direkten und indirekten Kosten der Schizophrenie , 1999 .

[71]  E. Rüther,et al.  [Direct and indirect costs of schizophrenia]. , 1999, Fortschritte der Neurologie Psychiatrie.

[72]  M. Smidt,et al.  Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[73]  D. Weinberger,et al.  From neuropathology to neurodevelopment , 1995, The Lancet.

[74]  Matthew H. Kaufman,et al.  The Atlas of Mouse Development , 1992 .